InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.045

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Notification regarding unquoted securities - IVX 27 May 2025 8:41AM $0.079 $0.045 fallen by 43.04%
$5 Application for quotation of securities - IVX 27 May 2025 8:33AM $0.079 $0.045 fallen by 43.04%
$5 Update - Notification regarding unquoted securities - IVX 15 May 2025 8:20AM $0.097 $0.045 fallen by 53.61%
$5 Notification regarding unquoted securities - IVX 14 May 2025 3:29PM $0.097 $0.045 fallen by 53.61%
$5 Results of Extraordinary General Meeting 9 May 2025 2:31PM $0.100 $0.045 fallen by 55%
$5 Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial 2 May 2025 9:05AM $0.098 $0.045 fallen by 54.08%
$5 Appendix 4C and Quarterly Activities Report - March 2025 30 Apr 2025 2:58PM $0.100 $0.045 fallen by 55%
$5 Notice of Extraordinary General Meeting/Proxy Form 8 Apr 2025 8:48AM $0.105 $0.045 fallen by 57.14%
$5 Section 708A Cleansing Statement 1 Apr 2025 8:44AM $0.100 $0.045 fallen by 55%
$5 Application for quotation of securities - IVX 1 Apr 2025 8:39AM $0.100 $0.045 fallen by 55%
$5 Section 708A Cleansing Statement 13 Mar 2025 2:57PM $0.110 $0.045 fallen by 59.09%
$5 Application for quotation of securities - IVX 13 Mar 2025 2:51PM $0.110 $0.045 fallen by 59.09%
$5 Update - Proposed issue of securities - IVX 11 Mar 2025 3:20PM $0.110 $0.045 fallen by 59.09%
$5 Cancel - Application for quotation of securities - IVX 5 Mar 2025 9:32AM $0.135 $0.045 fallen by 66.67%
$5 Share Purchase Agreement Termination and Tranche Repayment 5 Mar 2025 9:21AM $0.135 $0.045 fallen by 66.67%
$5 Section 708A Cleansing Statement 4 Mar 2025 2:49PM $0.140 $0.045 fallen by 67.86%
$5 Application for quotation of securities - IVX 4 Mar 2025 2:48PM $0.140 $0.045 fallen by 67.86%
$5 Proposed issue of securities - IVX 4 Mar 2025 10:49AM $0.140 $0.045 fallen by 67.86%
$5 Completion Of Placement to Accelerate Clinical Programs 4 Mar 2025 10:49AM $0.140 $0.045 fallen by 67.86%
$5 Appendix 4D and Half Year Financial Report 28 Feb 2025 3:16PM $0.140 $0.045 fallen by 67.86%
$5 Trading Halt 28 Feb 2025 9:14AM $0.140 $0.045 fallen by 67.86%
$5 Oesophageal Cancer Collaboration and Funding Agreement 26 Feb 2025 9:05AM $0.140 $0.045 fallen by 67.86%
$5 Activities Report and Appendix 4C 31 Jan 2025 9:52AM $0.180 $0.045 fallen by 75%
$5 Section 708A Cleansing Statement 23 Jan 2025 4:28PM $0.200 $0.045 fallen by 77.50%
$5 Application for quotation of securities - IVX 23 Jan 2025 4:26PM $0.200 $0.045 fallen by 77.50%

101 - 125 of 711 results

Page 5 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.